Brutkey

Kierkethumbs up convincingly
@Kierkegaanks@beige.party

One thing I don’t understand about how Eli Lilly and Novo Nordisk are being valued is how their share price can drop like 15% if their research for their next glp-1 product says the average weight loss is like 25% instead of 27% …

…when Americans still buy the Chinese knock-offs from Hims and Hers with unclear effects

Kevin Karhan :verified:
@kkarhan@infosec.space

@Kierkegaanks@beige.party I think #ForProfitHealthcare should be outlawed.
Espechally the #US system where it's treated as a commodity similar to Cable TV and Fast Food, instead of a #HumanRight!

https://www.youtube.com/watch?v=wO1IoKN0AkY
https://www.youtube.com/watch?v=YKlcY3CWr5g

#Healthcare #USpol #USA

Kierkethumbs up convincingly
@Kierkegaanks@beige.party

@kkarhan@infosec.space to be clear, eli and novo are pharmaceutical companies, and not private health insurers or providers

Kevin Karhan :verified:
@kkarhan@infosec.space

@Kierkegaanks@beige.party Yes but #Regulation in terms of #PharmaceuticalPricing and #Advertising works, as #Europe shows.
They still make more than a healthy margin wothout ripping off patients!

As #public|ly traded #corporations, their only allegiance is to their shareholders.
Otherwise they'd be #cooperatives!